Maura Arosio
-
- Pituitary Gland Disorders and Treatments 128
- Growth Hormone and Insulin-like Growth Factors 88
- Hormonal Regulation and Hypertension 20
- Adrenal Hormones and Disorders 20
- Surgery top 1%
- Adrenal and Paraganglionic Tumors 47
- Genetics top 2%
- Genetic Syndromes and Imprinting 12
- Behavioral Neuroscience top 5%
-
- Neuroendocrine Tumor Research Advances 20
-
- Ophthalmology and Eye Disorders 15
- Co-authors
- Paolo Beck‐PeccozG. FagliaIacopo ChiodiniAnna SpadaCristina L. RonchiAlfredo ScillitaniValentina MorelliPaolo Epaminonda
- Journals
- Annals of Internal Medicine (1 paper)PLoS ONE (2 papers)The Journal of Clinical Endocrinology & Metabolism (32 papers)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Maura Arosio
206 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 126
- Endocrinology, Diabetes and Metabolism 4.7k
- Endocrine and Autonomic Systems 342
- Surgery 2.1k
- Genetics 364
- Behavioral Neuroscience 115
Countries citing papers authored by Maura Arosio
This map shows the geographic impact of Maura Arosio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maura Arosio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maura Arosio more than expected).
Fields of papers citing papers by Maura Arosio
This network shows the impact of papers produced by Maura Arosio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maura Arosio. The network helps show where Maura Arosio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maura Arosio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 19 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 13 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 20 | |
| 14 | 2019 | 20 | |
| 15 | 2018 | 13 | |
| 16 | 2015 | 31 | |
| 17 | 2003 | 32 | |
| 18 | 2000 | 48 | |
| 19 | 1998 | 0 | |
| 20 | [Therapeutic use of somatostatin analogues in endocrinology]. | 1992 | 2 |
About Maura Arosio
Maura Arosio is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Reproductive Medicine, having authored 214 papers that have together received 6.0k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (128 papers), Growth Hormone and Insulin-like Growth Factors (88 papers), Adrenal and Paraganglionic Tumors (47 papers), Hormonal Regulation and Hypertension (20 papers), Neuroendocrine Tumor Research Advances (20 papers), Adrenal Hormones and Disorders (20 papers), Ophthalmology and Eye Disorders (15 papers) and Genetic Syndromes and Imprinting (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.7k citations), Endocrine and Autonomic Systems (342 citations) and Surgery (2.1k citations). Maura Arosio has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Paolo Beck‐Peccoz, G. Faglia, Iacopo Chiodini, Anna Spada, Cristina L. Ronchi, Alfredo Scillitani, Valentina Morelli, Paolo Epaminonda, Bruno Ambrosi and Emanuele Ferrante. Their work appears in journals such as Annals of Internal Medicine, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.